Celldex Therapeutics buy Citigroup Inc.
Start price
07.10.24
/
50%
€28.20
Target price
07.10.25
€63.74
Performance (%)
-20.57%
End price
08.10.25
€22.40
Summary
This prediction ended on 08.10.25 with a price of €22.40. The price of Celldex Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.57%. Citigroup_Inc_ has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 7.143% | 7.143% | 43.617% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€41.27
20.08.26
20.08.26
45.65%
12.03.26
12.03.26
